Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
The family of Henrietta Lacks has filed a federal lawsuit in Maryland against Novartis AG (NYSE:NVS) and Viatris Inc (NASDAQ:VTRS), alleging the companies profited unlawfully from the use of her tissue cells, known as "HeLa" cells.
亨莉埃塔 · 拉克斯的家人在馬里蘭州對諾華製藥（NYSE：NVS）和Viatris Inc（NASDAQ：VTRS）提起了聯邦訴訟，指控這些公司非法從使用其組織細胞（稱爲“HeLa”細胞）中獲利。
The Lacks estate claims these cells, which were taken without her knowledge in the 1950s, have been crucial to the companies' drug developments without any compensation or permission granted to her estate.
Lacks家族聲稱這些細胞是在20世紀50年代未經她知情便被取出，對這些公司的藥物開發至關重要，但她的遺產未獲得任何補償或授權。
Ben Crump, the Lacks family attorney, emphasized the historical exploitation of Black individuals in medical research, highlighting Lacks' story as a stark example.
Lacks家族律師本·克朗普強調了黑人在醫療研究中的歷史剝削，以拉克斯的故事爲鮮明例證。
The lawsuit follows previous actions against Thermo Fisher Scientific Inc (NYSE:TMO), which has since been settled, and ongoing litigation against Ultragenyx Pharmaceutical Inc (NASDAQ:RARE).
此訴訟是在之前對熱電費休爾科技公司（紐交所股票代碼：TMO）的訴訟得到解決之後進行的，並針對Ultragenyx Pharmaceutical Inc（納斯達克股票代碼：RARE）的持續訴訟。
Henrietta Lacks's cells were taken from her cervix during cancer treatment in 1951 at a Baltimore hospital.
亨麗埃塔·拉克斯的細胞是在巴爾的摩醫院進行癌症治療期間從她的子宮頸中取出的。
Reuters noted that these HeLa cells were the first to survive and reproduce indefinitely in lab conditions. Lacks passed away from cervical cancer later that year at the age of 31.
路透社指出，這些HeLa細胞是首批在實驗室條件下無限生長和繁殖的細胞。拉克斯當年因子宮頸癌去世，享年31歲。
The complaint details how Novartis allegedly used HeLa cells in the development of its herpes drug Famvir, cancer treatment Kymriah, and spinal muscular atrophy therapy Zolgensma.
起訴書詳細說明了諾華公司（Novartis）涉嫌在皰疹藥物Famvir、癌症治療Kymriah和脊髓性肌肉萎縮症療法Zolgensma的開發中使用HeLa細胞。
Viatris is accused of using these cells to test its herpes drug, Denavir, and depression treatment, Mylan-Mirtazapine.
Viatris被指控使用這些細胞測試其皰疹藥物Denavir和抗抑鬱症藥物Mylan-Mirtazapine。
The Lacks family seeks profits from the commercialization of HeLa cells and a court order to prevent further use without permission.
Lacks家族尋求從HeLa細胞的商業化獲得利潤，並獲得法院命令以防止未經許可進一步使用。
Price Action: At the last check on Tuesday, NVS stock was up 0.36% at $110.25, and VTRS stock was down 0.30% at $11.53.
股價行情：上次檢查時，NVS股價上漲0.36％至110.25美元，VTRS股價下跌0.30％至11.53美元。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明：本內容部分使用人工智能工具生成，並經Benzinga編輯審核發佈。